Login / Signup

A pharmacological master key mechanism that unlocks the selectivity filter gate in K+ channels.

Marcus ScheweHan SunÜmit MertAlexandra MackenzieAshley C W PikeFriederike SchulzCristina ConstantinKirsty S VowinkelLinus J ConradAytuğ K KiperWendy GonzálezMarianne MusinszkiMarie TegtmeierDavid C PrydeHassane BelabedMarc NazareBert L de GrootNiels DecherBernd FaklerElisabeth P CarpenterStephen J TuckerThomas Baukrowitz
Published in: Science (New York, N.Y.) (2019)
Potassium (K+) channels have been evolutionarily tuned for activation by diverse biological stimuli, and pharmacological activation is thought to target these specific gating mechanisms. Here we report a class of negatively charged activators (NCAs) that bypass the specific mechanisms but act as master keys to open K+ channels gated at their selectivity filter (SF), including many two-pore domain K+ (K2P) channels, voltage-gated hERG (human ether-à-go-go-related gene) channels and calcium (Ca2+)-activated big-conductance potassium (BK)-type channels. Functional analysis, x-ray crystallography, and molecular dynamics simulations revealed that the NCAs bind to similar sites below the SF, increase pore and SF K+ occupancy, and open the filter gate. These results uncover an unrecognized polypharmacology among K+ channel activators and highlight a filter gating machinery that is conserved across different families of K+ channels with implications for rational drug design.
Keyphrases
  • molecular dynamics simulations
  • minimally invasive
  • endothelial cells
  • emergency department
  • single cell
  • computed tomography
  • magnetic resonance imaging
  • dna methylation
  • drug induced